Daniel Joseph OConnell is President and CEO of Acumen Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Acumen Pharmaceuticals, Inc.
19 Jan 24
144
Acumen Pharmaceuticals, Inc.
19 Jan 24
4
Acumen Pharmaceuticals, Inc.
4 Jan 24
4
Acumen Pharmaceuticals, Inc.
18 Jan 23
4
Acumen Pharmaceuticals, Inc.
21 Jan 22
4
Acumen Pharmaceuticals, Inc.
2 Dec 21
4
Acumen Pharmaceuticals, Inc.
8 Jul 21
3
Acumen Pharmaceuticals, Inc.
30 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Jan 24 | ABOS Acumen Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 3.4706 | 15,200 | 52.75 k | 502,485 |
2 Jan 24 | ABOS Acumen Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 401,000 | 0.00 | 517,685 |
2 Jan 24 | ABOS Acumen Pharmaceuticals | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.23 | 602,000 | 2.55 mm | 602,000 |
17 Jan 23 | ABOS Acumen Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 114,000 | 0.00 | 116,685 |
17 Jan 23 | ABOS Acumen Pharmaceuticals | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.11 | 472,500 | 2.89 mm | 472,500 |